Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
NASDAQ:GILD
Gilead Sciences Inc. (GILD)
123.20
-0.56 (0.45%)
as of Jun 18, 2026, 10:18:29 pm Market Open.
113 watching
Financials 
Technical Analysis 0
BUY
COMMENT
Anybody who bought this stock over the past number of years has made a profit because this one is near its historical highs. Company doesn’t interest him because it has done too well. Did a takeover which muddied the balance sheet so it is pretty ugly. Insiders have been selling an awful lot of the company.
biotechnologypharmaceutical
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Biotech group has been performing extremely well. There is growth and there is an expectation that they will be bought by a traditional drug company. You are buying something for growth here. Prefers to own the group, such as XBI-N, an ETF.